The Safe Use Initiative and health literacy
Subtitle: workshop summary
By: Cori Vancheri, rapporteur ; Roundtable on Health Literacy, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
Contributors: Institute of Medicine (U.S.). Roundtable on Health Literacy; United States. Food and Drug Administration; National Academies Press (U.S.)
Publisher: National Academies Press
Published: 2010
Place of publication: Washington, D.C
Language: eng
Number of pages: 73
ISBN-13: 9780309159319
Subjects: Safety measures; Drug Legislation; Drugs; Safety Management; Health Policy; Congresses; Pharmaceutical policy; Patient education; Drug Toxicity; Health Literacy; Pharmacy Legislation
Description: "Every year at least 1.5 million people suffer adverse effects from medication. These problems occur because people misunderstand labels, are unaware of drug interactions, or otherwise use medication improperly. The Food and Drug Administration's Safe Use Initiative seeks to identify preventable medication risks and develop solutions to them. The IOM held a workshop to discuss the FDA's Safe Use Initiative and other efforts to improve drug labeling and safety."--
Notes: Includes bibliographical references (p. 57-59).

Also issued online.
Table of contents: title: Introduction; title: FDA Safe Use Initiative; title: Over-the-counter products; title: Initiatives to advance patient-centered drug safety; title: Identifying activities around which to build partnerships for patient-centered drug safety; title: How can the lessons of health literacy be used to build patient-centered outcomes for safe use?